Clinical Study
Improving Total-Cholesterol/HDL-Cholesterol Ratio Results in an Endothelial Dysfunction Recovery in Peripheral Artery Disease Patients
Table 1
Demographic data and treatment.
| | | Treatment group | Control group | | | | (75) (%) | (75) (%) |
| | Age | 71.4 ± 10.8 | 70.51 ± 9.7 | n.s | | Male | 65 (87) | 62 (82.6) | n.s | | Hypertension | 55 (73.3) | 57 (76) | n.s | | DM | 30 (40) | 33 (44) | n.s | | Current smoking | 41 (55) | 39 (52) | n.s | | Ex smoker | 26 (35) | 32 (42.6) | n.s | | AMI | 10 (14) | 8 (10.6) | n.s | | Dyslipidaemia | 18 (25) | 12 (16) | n.s | | CVA | 5 (6.6) | 6 (8) | n.s | | Antiplatelet treatment | 65 (86.6) | 69 (92) | n.s | | ACE inhibitors | 35 (46.7) | 30 (40) | n.s | | ARA-II | 10 (13.3) | 8 (10.6) | n.s | | B-blocker | 11 (14.6) | 12 (16) | n.s | | Nitrites | 5 (6.7) | 3 (4) | n.s | | CA antagonists | 15 (20) | 17 (22.6) | n.s |
|
|
DM: diabetes mellitus; AMI: acute myocardial infarction; CVA: cerebrovascular accident.
|
